CH

Chai Communication Co., LTD.

An Ad-Tech firm providing digital marketing, SEO, social media, and creative ad solutions.

351870 | KO

Overview

Corporate Details

ISIN(s):
KR7351870001
LEI:
Country:
South Korea
Address:
서울특별시 강남구 학동로43길 6, 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Chai Communication Co., Ltd. is an AD-Tech based comprehensive digital advertising and marketing company. Established in 2004, the company offers a full suite of digital marketing services, including online advertising campaigns, social media marketing, keyword search optimization, and advertising production such as brand films and banner ads. Chai Communication leverages data and technology to deliver creative and effective advertising solutions, aiming to create a distinct difference for its clients' brands in the digital space.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 392.6 KB
2025-08-29 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-07-31 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 397.7 KB
2025-07-28 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 402.4 KB
2025-07-11 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 407.1 KB
2025-06-26 00:00
M&A Activity
타법인주식및출자증권취득결정
Korean 25.0 KB
2025-06-13 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 413.1 KB
2025-05-30 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.4 MB
2025-05-30 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 420.1 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 32.9 KB
2025-03-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.4 KB
2025-03-31 00:00
Remuneration Information
주식매수선택권부여에관한신고
Korean 164.9 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 25.8 KB
2025-03-21 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 450.2 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 220.0 KB

Automate Your Workflow. Get a real-time feed of all Chai Communication Co., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Chai Communication Co., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Chai Communication Co., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan
4564

Talk to a Data Expert

Have a question? We'll get back to you promptly.